Timing for Nuvilex, Inc (OTCQB: NVLX) Shareholders May Be

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 26, 2013 at 2:45 PM

Timing for Nuvilex, Inc (OTCQB: NVLX) Shareholders May Be Perfect With Growing Medical Marijuana Movement

SAN DIEGO, CA--(Marketwired - Jul 26, 2013) - The OTC Journal, the longest running electronic newsletter focused on the small cap and microcap sectors, notes Nuvilex's ( OTCQB : NVLX ) efforts to study the potential applications of its proprietary encapsulation technology to enhance the efficacy of cannabidiol (CBD)-based cancer treatments may line up perfectly with the Medical Marijuana legalization movement in the US.

At present, Marijuana use is estimated at $54 billion in the US. It is legal for prescribed use in 18 states. Two states, Colorado and Washington, have legalized marijuana use for recreational purposes. The Justice Department has clearly stated a "no prosecutions" policy for prescribed medicinal use. No such statement has been forthcoming regarding recreational use, and interested parties are anxiously awaiting clarification from Attorney General Eric Holder.

The 2012 elections created a storm of interest in the sector when voters in Washington and Colorado legalized small amounts of marijuana for recreational use in their states. About 20 small public companies enjoyed major price and volume appreciation -- anywhere from 100% to 2500%.

5 states currently have pending legislation to legalize medicinal marijuana use: Illinois, Minnesota, New York, Ohio, and Pennsylvania. New Hampshire became the 19^th to legalize physician prescribed Marijuana use this past week.

Two states have recently decriminalized the possession of small amounts: Texas and Vermont.

A comprehensive drug policy report, 400 pages in length, was released by the Organization of American States this past May. The report gave considerable weight to the legalization or de-penalizing of Marijuana. The report points out the US has spent many billions attempting to stop the flows of Marijuana with little effect.

Since Nuvilex ( OTCQB : NVLX ) completed a recent financing and procured the final global rights to the encapsulation technology for all cancer treatments, the company can now vigorously pursue its use with a Cannabinoid therapies that are growing in popularity for cancer treatment.

The coming 2013 elections are likely to bring new legalization initiatives and create a resurgence of interest in the stocks of Cannabis related companies.

Nuvilex ( OTCQB : NVLX ) shareholders could be positioned to benefit greatly as the company continues to explore this potential application for its technology.

For an archive of previous OTC Journal editions on Nuvilex ( OTCQB : NVLX ), visit the following URL:

http://www.otcjournal.com/Nuvilex/NVLX/af/profile/

Additional detail via the OTC Journal article as well as associated disclaimers can be accessed or downloaded in their entirety by visiting www.otcjournal.com .

About The OTC Journal: The OTC Journal is the longest running electronic newsletter committed to small and microcap stocks. Published continuously since 1998, the OTC Journal provides readers with short term trading ideas, long term ongoing coverage of worthy small and microcap companies, and overall market commentary.

The OTC Journal is also an investor relations firm that publishes a newsletter that provides a forum for issuers who wish to advertise their company. To read our publication, including information regarding our compensation, visit www.otcjournal.com .

About Nuvilex, Inc. ( OTCQB : NVLX ): Nuvilex, Inc. has been a provider of all-natural products for many years, has expanded its company to increase its natural product based footprint through medical marijuana studies and is becoming an international biotechnology provider of live, therapeutically valuable, encapsulated cells and services for treatments, research and medicine. The Company's offerings will ultimately include cancer, diabetes and other clinical treatments using the company's natural product knowledge, product base, cell and gene therapy expertise, and live-cell encapsulation technology in addition to other new products currently under development. For more information visit: www.nuvilex.com .

OTC Journal Larry Isen Publisher editor@otcjournal.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Sintilimab Poised for New Milestone in Melanoma Fight

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

HCLTech Partners with Rapidus on Semiconductor Future

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

D-Wave Investors Must Decide by Dec 15 Class Suit

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Clarins Dazzles Austin with Skin Longevity Event

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

BAIC FOTON Eyes African Market with Strategic Moves

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Dar Global Eyes Dubai for Strategic Real Estate Moves

Tapping into Dubai's Real Estate Allure Every seasoned investor knows the real estate game ain't for the faint of heart, especially when you’re playing in a market as competitive as Dubai's. But here comes Dar Global Capital Partners (DGCP), throwing their hat into the ring with a fresh strategy centered around high-value real estate. Sure, they aren't new to the...